重组细胞因子

• Oral Saccharomyces cerevisiae-Guided Enzyme Prodrug Therapy Combined with Immunotherapy for the Treatment of Orthotopic Colorectal Cancer. ACS Nano. 2024 Aug 27;18(34):23497-23507. (IF 15.8)(Mouse GM-CSF, Mouse IL-4)
• Ameliorating Lung Fibrosis and Pulmonary Function in diabetic mice: Therapeutic Potential of Mesenchymal Stem Cell. Biochem Biophys Res Commun. 2024 Aug 5:737:150495. (IF 2.5)(Mouse M-CSF)
• DNA Origami Enhanced Cytokine Immunotherapy for Alleviating Renal Ischemia-Reperfusion Injury. ACS Appl Mater Interfaces. 2024 Jul 19. (IF 8.7)(Mouse M-CSF)
• Dual-Engineered Macrophage-Microbe Encapsulation for Metastasis Immunotherapy. Adv Mater. 2024 Jul 18:e2406140. (IF 27.4)(Mouse CCL2)
• Lyssavirus matrix protein inhibits NLRP3 inflammasome assembly by binding to NLRP3. Cell Rep. 2024 Jul 9;43(7):114478. (IF 7.5)(Mouse GM-CSF)
• Oral microsphere formulation of M2 macrophage-mimetic Janus nanomotor for targeted therapy of ulcerative colitis. Sci Adv. 2024 Jun 28;10(26):eado6798. (IF11.7)(Mouse IL-4)